Article
San Francisco - Of all the dilemmas that dermatologists confront in the clinical setting, few are as disturbing as the risk of exposure to human immunodeficiency virus (HIV) due to a needle stick.
The Unprecedented Phase 1 Results of ET-02 for the Treatment of Androgenic Alopecia
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
LEO Pharma and Gilead Will Develop STAT6 Program for AD and Other Inflammatory Diseases
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
MCADT Model Advances Melanoma Detection
Identifying Ancestry-Specific Clinical End Points in Diverse Trials